Search

Your search keyword '"Nishimiya H"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Nishimiya H" Remove constraint Author: "Nishimiya H"
49 results on '"Nishimiya H"'

Search Results

1. Search for the $K_{L} \to \pi^{0} \nu \bar{\nu}$ Decay at the J-PARC KOTO Experiment

2. Study of the $K_L \!\to\! \pi^0 \nu \overline{\nu}$ Decay at the J-PARC KOTO Experiment

3. First Search for the $K_L \to \pi^0 \gamma$ Decay

4. Study of the KL→π0νν¯ Decay at the J-PARC KOTO Experiment

5. Search for $K_L \!\to\! \pi^0 \nu \overline{\nu}$ and $K_L \!\to\! \pi^0 X^0$ Decays at the J-PARC KOTO Experiment

6. Study of the $K_L \!\to\! ��^0 ��\overline��$ Decay at the J-PARC KOTO Experiment

7. First Search for the $K_L \to ��^0 ��$ Decay

8. Search for <math><mrow><msub><mrow><mi>K</mi></mrow><mrow><mi>L</mi></mrow></msub><mo>→</mo><msup><mrow><mi>π</mi></mrow><mrow><mn>0</mn></mrow></msup><mi>ν</mi><mover><mrow><mi>ν</mi></mrow><mrow><mo>¯</mo></mrow></mover></mrow></math> and <math><msub><mi>K</mi><mi>L</mi></msub><mo>→</mo><msup><mi>π</mi><mn>0</mn></msup><msup><mi>X</mi><mn>0</mn></msup></math> Decays at the J-PARC KOTO Experiment

16. Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis

17. Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer

18. Results of randomised controlled phase II study (KBCSG02 trial) of the efficiency of palonosetron, aprepitant, and dexamethasone for day1 with or without dexamethasone on days2 and 3.

19. The effectiveness of pretreatment video-based psychoeducation for patients with breast cancer.

20. A novel telerehabilitation with an educational program for caregivers using telelecture is feasible for fall prevention in elderly people: A case series.

21. Study of the K&#95;{L}→π^{0}νν[over ¯] Decay at the J-PARC KOTO Experiment.

22. Minor impact of patient alloantibodies against human platelet antigen (HPA)-15 in the effectiveness of platelet transfusion: A pilot study.

23. [In Situ Ductal Carcinoma with Hereditary Breast and Ovarian Cancer Syndrome in a Patient Who Received Contralateral Risk-Reducing Mastectomy-A Case Report].

24. BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study.

25. A novel simple assay system for the detection of human platelet antigen 15 (HPA-15) alloantibodies based on three techniques: an HPA-15 expressing cell line, a monoclonal antibody-specific antigen-capture method and mixed-passive haemagglutination.

26. Lymphocyte-Monocyte Ratio Significantly Predicts Recurrence in Papillary Thyroid Cancer.

27. Analysis of the selection of CDK4/6 inhibitors based on experience using palbociclib.

29. Differential Prognostic Relevance of Promoter DNA Methylation of CDO1 and HOPX in Primary Breast Cancer.

30. Search for K&#95;{L}→π^{0}νν[over ¯] and K&#95;{L}→π^{0}X^{0} Decays at the J-PARC KOTO Experiment.

31. Lymph node metastasis and high serum CEA are important prognostic factors in hormone receptor positive and HER2 negative breast cancer.

32. BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

33. Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy.

34. Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer.

35. Aberrant methylation of GCNT2 is tightly related to lymph node metastasis of primary CRC.

36. Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer.

37. N-acetyl cysteine alleviates inflammatory reaction of oral epithelial cells to poly (methyl methacrylate) extract.

38. Usefulness of MRI of microcalcification lesions to determine the indication for stereotactic mammotome biopsy.

39. The safety of concentrated trastuzumab in 100 ml of saline solution for administration to patients with HER2-positive breast cancer: a phase 1 study.

40. Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-up.

41. [A case of facial nerve palsy induced by nab-paclitaxel].

42. DNA damage-inducible gene, reprimo functions as a tumor suppressor and is suppressed by promoter methylation in gastric cancer.

43. [Efficacy and safety of lidocaine hydrochloride jelly for the treatment of pain caused by breast cancer metastases to the skin].

44. [A rare case of huge triple-negative of accessory breast cancer enlarged during the course of chemotherapy].

45. Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer.

Catalog

Books, media, physical & digital resources